Aoki Taro, Hyuga Satoshi, Kato Aya, Chono Teruhiro, Watanabe Risa, Komori Takamichi, Matsumoto Takashi, Takachi Kou, Nishioka Kiyonori, Uemura Yoshio, Kobayashi Kenji
Dept. of Surgery, Kinki Central Hospital, Japan.
Gan To Kagaku Ryoho. 2012 Nov;39(12):1855-6.
Duodenal stenting for malignant disease related to gastric outlet obstruction(GOO) has been covered by health insurance in Japan since April 2010. We inserted WallFlexTM duodenal stents(WDS) in 4 patients with GOO caused by unresectable gastric cancer. WDS insertion was successful in all 4 cases. Duodenal perforation occurred in 1 case. One case each of stent obstruction and stent migration occurred. All patients could eat a soft-food diet for 3-6 months (median, 5.3 months). Survival time ranged between 5 and 14 months (median, 6 months). Three patients underwent S-1 combination chemotherapy. Duodenal stenting is expected to be effective for advanced gastric cancer related to GOO.
自2010年4月起，十二指肠支架置入术治疗与胃出口梗阻（GOO）相关的恶性疾病在日本已纳入医保范围。我们为4例因无法切除的胃癌导致胃出口梗阻的患者置入了WallFlexTM十二指肠支架（WDS）。4例患者WDS置入均成功。发生十二指肠穿孔1例。各发生支架梗阻和支架移位1例。所有患者均能进食软食3至6个月（中位数为5.3个月）。生存时间为5至14个月（中位数为6个月）。3例患者接受了S-1联合化疗。十二指肠支架置入术有望对与胃出口梗阻相关的晚期胃癌有效。
Zotero 插件